Pulling SEC filings + quote and writing the call…

Criteo S.A.
Next earnings Jul 28, 2026 (before open) · consensus $0.72 EPS, $268M rev
Last earnings -21.2% on 2026-05-06
CRTO at 6.8x earnings with $342M cash, accelerating margins and aggressive buybacks — a cheap, cash-generative ad-tech turnaround.
P/E ratio 6.8 · FY2025
Quality fundamentals and an attractive price line up (~366% below fair value) — the rarer case where both the business and the entry look good.
Criteo is quietly executing a credible margin turnaround at a giveaway valuation. FY2025 revenue was essentially flat at $1.94B (+0.6% YoY), but the quality of earnings underneath improved sharply: operating income jumped 33.9% to $203M, net income rose 29.6% to $145M, and diluted EPS climbed 38.9% to $2.64 — a 6.8x P/E and 0.5x P/S on a business throwing off $311M of operating cash flow (+20.6%). Gross margin of 54% and ROE of 12.6% are healthy for ad-tech, and the balance sheet is a fortress: $342M cash, near-zero debt (long-term debt of just $1.5M per the data), and liabilities/equity of 0.88x that actually fell 14.3% YoY.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.25B | $2.02B | $1.95B | $1.93B | $1.94B |
| Gross profit | $782M | $795M | $863M | $983M | $1.05B |
| Operating income | $152M | $24.3M | $77.2M | $151M | $203M |
| Net income | $134M | $8.95M | $53.3M | $112M | $145M |
| Diluted EPS | $2.09 | $0.14 | $0.88 | $1.90 | $2.64 |
| Net margin | 6.0% | 0.4% | 2.7% | 5.8% | 7.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
2026 proxy: director slate, say-on-pay and routine governance items
Q1 2026 10-Q filed; ongoing disclosure with no flagged control issues
Q1 2026 10-Q filed; ongoing disclosure with no flagged control issues
FY2025 10-K amendment (Part III proxy info); not a restatement
FY2025 10-K amendment (Part III proxy info); not a restatement
Annual shareholder vote results disclosed; routine governance item
FY25 10-K: rev $1.94B, op inc +34%, ICFR effective, $67M buyback left
Other-events disclosure; non-material corporate update
FY2025 results: EPS +39%, net income +30%, OCF +21% — strong beat
Sources: SEC EDGAR (CIK 0001576427, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/25/2026, 2:44:53 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 6 sales
| 2026-06-01 | Glickman Sarah JS Chief Financial Officer | Sell | 982.00 @ $18.50 | $18.2K |
| 2026-06-01 | Damon Ryan Chief Legal Officer | Sell | 1.08K @ $18.50 | $20.0K |
| 2026-05-26 | Glickman Sarah JS Chief Financial Officer | Sell | 1.31K @ $17.06 | $22.4K |
| 2026-05-26 | Glickman Sarah JS Chief Financial Officer | Sell | 1.15K @ $17.06 | $19.7K |
| 2026-05-26 | Damon Ryan Chief Legal Officer | Sell | 1.14K @ $17.06 | $19.4K |
| 2026-05-26 | Damon Ryan Chief Legal Officer | Sell | 996.00 @ $17.06 | $17.0K |
| 2026-03-13 | van der Kooi Frederik Director | Buy | 5.00K @ $17.81 | $89.0K |
| 2026-03-13 | Damon Ryan Chief Legal Officer | Award | 63.3K | |
| 2026-03-13 | Glickman Sarah JS Chief Financial Officer | Award | 83.5K | |
| 2026-03-13 | Komasinski Michael CEO | Award | 142K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1043 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.